Core Viewpoint - MicroPort Medical's stock experienced a decline of 5.62% on August 8, trading at 13.09 yuan per share with a transaction volume of 5.06 billion yuan, indicating market volatility and investor sentiment concerns [1]. Group 1: Company Overview - MicroPort Medical Science Co., Ltd. is a multinational enterprise group focused on innovative medical technologies in various fields, including cardiovascular, cerebrovascular, nervous system, and orthopedics [1]. - The company aims to provide accessible medical solutions and has established innovation centers and production bases in multiple regions globally [1]. - MicroPort's products are available in over 100 countries and regions, contributing to life-saving and life-extending medical interventions [1]. Group 2: Financial Performance - As of the 2024 annual report, MicroPort Medical reported total revenue of 7.412 billion yuan and a net loss of 1.539 billion yuan [2].
微创医疗(00853)下跌5.62%，报13.09元/股